PRPerrigo PRGO · NYSE
$16.09 -3.25% (-$0.54)
- Market cap
- $2.23B
- Enterprise value
- $5.12B
- P/E
- -
- Forward P/E
- 7.1x
- PEG
- -
- P/S
- 0.5x
- P/FCF
- 12.7x
- EV/EBITDA
- -
- ROIC
- 3.5%
- Gross margin
- 33.3%
- Net margin
- -41.9%
- Dividend yield
- 7.21%
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.54
- Free float
- 99.8%
About the company
Perrigo Company plc is a global company specializing in the manufacturing and distribution of over-the-counter medications, generic drugs, and healthcare products. With over 130 years of history, the company focuses on providing accessible, high-quality, and safe products to consumers worldwide. Its portfolio includes a wide range of products, from over-the-counter pain relievers to skincare products and vitamins. Perrigo operates manufacturing and distribution facilities across multiple continents.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Albert A. Manzone
Employees
8,100
Headquarters
Dublin
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number